RF Radiation, Rising Tumor Trends, and Low-Fidelity Biology

Stop using the lumped rate to hide the tumors that are rising.

That is the starting point of this RF Safe argument. A single headline about “brain cancer” cannot tell us what is happening to every tumor type, every age group, or every tissue close to a wireless handset. Nor can a limit built around preventing excessive heating, by itself, settle every question about repeated exposure across a lifetime.

The challenge is to connect those questions without pretending that the connections have already been proved. Tumor registries describe populations. Animal experiments test hazards under defined conditions. Mechanistic research asks how an effect could happen. RF Safe’s low-fidelity biology framework proposes how repeated disturbances might lower biological reserve and make other insults more consequential. These are different layers of an argument, and each deserves to be examined on its own terms.

A champion’s diagnosis, and the questions it raises

Archie Goodburn’s public account of living with three oligodendrogliomas puts a person in front of a category that can otherwise disappear into a statistical table. In an August 6, 2026 commentary, Alasdair Philips and Denis Henshaw of the EM Radiation Research Trust used his diagnosis as a reason to revisit English registry data. Their analysis focused on the much rarer oligodendroglioma, including younger adults, using historical records through 2015. Read their commentary.

They reported an approximately fourfold increase in the aggressive Grade 3 category over the period beginning in 1995, with a steep rise from around 1997. They also emphasized how uncommon the disease remained: the reported incidence was below one case per 100,000 people per year. Both facts belong in the same sentence. A large relative change in a rare disease is consequential, but it is not a large absolute probability for every individual.

Their earlier peer-reviewed England analysis reported that age-standardized glioblastoma incidence rose from 2.4 to 5.0 per 100,000 between 1995 and 2015, while annual cases increased from 983 to 2,531. The authors argued that environmental or lifestyle explanations required investigation. Philips and colleagues, 2018.

RF Safe’s position is that these limitations should sharpen the next investigation. They should not become a reason to stop asking. An explanation based on improved detection needs to be tested against the distribution of grades, ages, and locations, rather than assumed to explain every change.

What the U.S. tumor categories actually show

Joel Moskowitz’s May 2026 update presents selected age-adjusted SEER trends through 2023. The figures below reproduce that reported extraction, rather than a new independent analysis of patient-level registry records. Moskowitz’s SEER analysis and linked queries.

The distinction between malignant and nonmalignant disease matters. A tumor can cause substantial harm without being classified as malignant. Its location can make growth dangerous; treatment and its consequences can profoundly affect a life. “Nonmalignant” should never be used as a synonym for inconsequential. It is also a meaningful pathological classification, not merely a billing label.

RF Safe’s concern is anatomical as well as statistical: a handset can expose tissues around the head and neck, including the brain and salivary region. That makes careful organ-specific research reasonable. It does not make every tumor in those regions an RF-related tumor. The exposure distribution must be measured, and competing explanations must be evaluated.

Children and younger adults deserve particular attention in that research agenda. Their developmental timing, future years of exposure, and disease patterns cannot be represented by a single average across the whole population. The appropriate next step is age-specific surveillance linked to credible exposure assessment—not assigning a cause to a young person’s illness from age alone.

Human evidence: concern, disagreement, and what remains unresolved

A 2020 meta-analysis by Choi, Moskowitz and colleagues reported an odds ratio of 1.60 for tumors in the subgroup with at least 1,000 cumulative hours of cellular-phone use. That is the source of the often-repeated “60% higher” figure. It is a relative association from a subgroup of observational studies, not a measured 60% lifetime probability of cancer and not a threshold at which a phone suddenly becomes dangerous. Read the original meta-analysis.

One thousand hours spread evenly across ten years is about 16.4 minutes per day. The arithmetic makes the exposure category understandable; it does not reproduce the study participants’ actual patterns, handset powers, network conditions, or absorbed doses.

The wider literature does not speak with one voice. A 2024 WHO-commissioned systematic review by Karipidis and colleagues found moderate-certainty evidence that mobile-phone use likely does not increase risk for several of the most studied tumors, including glioma, meningioma, acoustic neuroma, and salivary-gland tumors. This is substantial contrary evidence that an evidence-forward RF Safe article must acknowledge. Read the 2024 human evidence review.

In 2011, IARC classified RF electromagnetic fields as possibly carcinogenic to humans, Group 2B. That classification expresses a level of evidence for a potential hazard; it neither proves causation in an individual nor supplies a numerical estimate for everyday exposure. IARC’s classification announcement.

The productive disagreement is about study quality, exposure misclassification, recall, latency, and the ability of different designs to detect risks in heavily exposed or susceptible groups. RF Safe argues for better measurement and continued investigation. That argument is stronger when it explains the reassuring studies as well as the concerning ones.

The limit was not derived as a lifetime cancer-risk number

SAR—specific absorption rate—describes the rate of RF energy absorption per unit mass, expressed in watts per kilogram. It is not simply “energy that arrived in an hour.” A whole-body average and a localized tissue average are different quantities and must not be compared as though they describe the same exposure.

The FCC’s public whole-body SAR limit is 0.08 W/kg, or 80 mW/kg. The rule separately specifies a localized limit of 1.6 W/kg averaged over one gram of tissue, with exceptions for extremities. This distinction is essential when discussing a risk assessment based on whole-body animal exposures alongside a phone’s reported localized SAR. 47 CFR §1.1310.

The National Toxicology Program reported clear evidence of malignant heart schwannomas and some evidence of malignant gliomas in male rats under its experimental conditions. These were controlled, long-duration animal exposures. NTP cautions against directly equating them with typical human cellphone use. NTP’s findings and exposure context.

The WHO-commissioned animal review by Mevissen and colleagues likewise identified a strong signal for heart schwannomas in male rats, while emphasizing the difficulty of translating animal findings into human RF risk. Most organ systems did not show comparable evidence. Its publication record also lists a 2026 corrigendum; the review should be consulted together with that correction. Animal review · Corrigendum record.

In March 2026, Ronald Melnick and Joel Moskowitz published a quantitative challenge to current limits. Their model used animal tumor data, benchmark-dose methods, and linear extrapolation to estimate a one-in-100,000 excess cancer-risk level. They reported roughly 0.8–5 mW/kg for the specified one-hour daily scenario, with exposure duration changing the comparison. Across scenarios, they estimated current limits were 15–900 times higher. Their male-reproductive assessment yielded 3.3–10 mW/kg, or approximately 8–24 times below 80 mW/kg. Melnick and Moskowitz, 2026.

The policy question remains legitimate: do the assumptions supporting an exposure standard adequately address endpoints beyond excessive heating? Compliance establishes that a specified rule has been met. It does not establish that every chronic endpoint, every waveform, and every susceptibility has been conclusively studied.

Low-fidelity biology: RF Safe’s proposed systems model

RF Safe calls the proposed upstream state low-fidelity biology: a loss of precision in biological timing, repair, and recovery. The idea is not that one environmental exposure must be the final cause of every disease. It is that an exposure could reduce reserve so that genetic, chemical, metabolic, infectious, or developmental stresses become harder to absorb.

In this model, the cell still runs. The concern is that it runs with less reliable coordination. Calcium pulses, mitochondrial responses, transcription, and repair are not interchangeable measures of “activity.” Their sequence and timing can matter. A signal that arrives too early, lasts too long, or fails to terminate could have a different consequence from a correctly timed signal of the same average size.

Bioelectrical dissonance is the author’s term for the proposed mismatch. Recovery debt describes the proposed accumulation of unfinished restoration when disturbances recur before the system returns to baseline. Meta-disease state means an upstream susceptibility model, not a recognized diagnosis and not a demonstrated cause of the registry trends above.

S4: the timing interface

The S4 region is part of the voltage-sensing machinery of voltage-gated ion channels. RF Safe proposes that some time-structured exposures could disturb gating precision and calcium coding. Earlier published hypotheses, including Pall’s VGCC proposal, motivate channel-mediated investigation. They do not establish a validated coupling mechanism for every wireless signal at ordinary environmental levels. Pall’s 2013 mechanistic proposal.

For this branch, the important proposed endpoint is not simply “more calcium.” It is a changed waveform: phase, pulse spacing, localization, amplitude, jitter, and return to baseline. The experimental challenge is to show a reproducible change under well-characterized exposure and then establish the biological route that produces it.

Mito: the amplifier

Mitochondria couple calcium handling to metabolism and redox balance. Within the framework, mistimed input could reduce energetic reserve or alter reactive-species production. RF Safe proposes that tissues combining demanding electrical activity, mitochondrial dependence, and limited replacement may be especially informative. That is a tissue-selection hypothesis to test; it is not an established explanation for why particular animal tumors occurred.

Spin: a second candidate receiver

The spin branch asks whether relevant radical-pair or related redox chemistry could respond to particular fields. Heme, flavin, and iron-sulfur chemistry are candidates within the author’s mechanism map. Naming a candidate does not show that a telecom waveform couples to it in living tissue. The model needs experiments that identify the molecule, the field conditions, the reaction, and the downstream consequence.

The persistence gate

The persistence gate asks a separate question: even if an acute change occurs, is it erased or retained? A transient laboratory response is not automatically disease. RF Safe proposes that repeated disturbances may become consequential when recovery is incomplete, especially in long-lived cellular systems. Measurements after exposure ends are therefore as important as measurements during exposure.

What CYB5B adds—and the bridge still to be built

A 2026 Cell study by Kim and colleagues reported an electromagnetic-field-inducible gene switch and identified Cyb5b through a CRISPR screen as an essential mediator. The work connected controlled field exposure to calcium oscillations and gene activation in an engineered experimental system. Kim and colleagues, Cell.

For the low-fidelity framework, that is a reason to ask more precise questions about molecular transduction and timing. It is not direct proof that a phone, router, or base station activates the same pathway, causes cancer, or accelerates human aging. The engineered system and its laboratory field conditions matter. The journal also published an erratum, linked from the authors’ institutional publication record.

A useful next experiment would compare the demonstrated stimulus with independently characterized telecom exposures, include temperature-matched sham conditions, and measure whether loss and restoration of the candidate protein changes the result. A molecular requirement under one stimulus is a starting point for that bridge, not permission to assume the bridge exists.

Thirteen proposed routes from repeated disturbance to reduced reserve

The following pathways preserve the author’s proposed aging architecture. They describe testable routes through which a persistent disturbance might amplify other stresses. They are not thirteen established effects of everyday wireless exposure in humans.

1. Calcium timing errors. Irregular gating could change the timing and localization of calcium signals. The key test is whether the distortion is reproducible and functionally meaningful, rather than merely a change in a single average concentration.
2. Mitochondrial transduction. CYB5B-like pathways offer candidate molecular entry points. The necessary bridge is to demonstrate relevant coupling under the exposure of interest, rather than generalizing from an engineered gene switch.
3. Oxidative and nitrosative load. Reactive species could amplify an initial perturbation. A 2024 systematic review rated the RF–oxidative-stress evidence very low certainty because of bias and heterogeneity; the pathway remains a research question, not a settled human outcome. Meyer and colleagues.
4. Bioenergetic decline. If calcium–redox coupling is persistently altered, ATP reserve and mitochondrial quality control are possible downstream measures. A hypothesis about reserve should predict how much recovery is lost and whether it returns.
5. Cellular senescence. The framework asks whether a persistent disturbance increases stable senescence, rather than a transient stress response. Multiple markers, recovery periods, and functional assays would be needed to separate those possibilities.
6. Genomic instability and repair. A proposed route is that oxidative lesions or impaired repair increase retained errors. Demonstrating DNA damage alone would not establish cancer causation; the timing, persistence, repair response, and exposure relevance must also be shown.
7. Loss of protein quality control. Proteostasis is another proposed reserve system. The research question is whether exposure changes protein folding or clearance in a durable, reproducible way after ordinary adaptive responses are accounted for.
8. Unresolved inflammation. In the model, incomplete recovery could sustain inflammatory signaling. Researchers would need to distinguish a short-lived protective response from damaging chronic inflammation and identify what maintains it.
9. Transcriptional noise and epigenetic drift. Mistimed signaling might alter gene-expression coordination. A changed transcript is not itself evidence of aging; the model should predict persistent changes in function, identity, or repair.
10. Recovery-debt accumulation. This is the central persistence claim: closely spaced perturbations should have different effects from otherwise comparable exposures with sufficient recovery. It can be tested directly with carefully matched schedules.
11. Stem and progenitor reserve. The framework proposes reduced regenerative capacity as a downstream possibility. Tests should measure differentiation and repair function, not assume that a laboratory stress marker implies exhausted stem cells.
12. Oscillatory and circadian coordination. The author proposes that disrupted biological timing could reduce nightly restoration. Experiments must separate RF exposure from screen light, behavior, sleep opportunity, and other correlated influences.
13. Multi-hit amplification. The most consequential prediction is interaction: an exposure that has little effect alone might alter the response to a second stressor. A factorial design can test whether the combined effect is additive, synergistic, absent, or protective.

These routes converge on the author’s central proposition: disease risk may rise when an organism’s capacity to maintain accurate timing and recover from stress is reduced. That proposition does not identify RF as the sole or dominant cause of aging. It asks whether some exposure conditions can become a contributor—and what measurements would establish or rule out that contribution.

Eight experiments that could strengthen—or weaken—the model

A mechanism map earns its place by making predictions that can fail. The following is an expanded research agenda derived from RF Safe’s thesis, not a list of findings already demonstrated.

1. Match average dose, vary timing. Compare different pulse patterns at matched absorbed dose and controlled temperature. A timing-specific theory predicts differences beyond total energy alone.
2. Scramble the waveform. Preserve specified spectral and dose characteristics while altering temporal organization. Prespecify which calcium or recovery metric should change.
3. Measure calcium fidelity. Record phase, inter-pulse intervals, localization, and termination, not only peak concentration. Test whether changes precede downstream effects.
4. Interrupt the proposed branch. Use genetic perturbation with rescue experiments, alongside suitable controls, to test whether a candidate channel or protein is required.
5. Measure mitochondrial reserve. Ask whether a signaling change predicts altered respiratory reserve or redox recovery, and whether restoring the proposed upstream function prevents it.
6. Vary recovery intervals. Hold the specified cumulative exposure constant while changing spacing. If recovery debt matters, spacing should systematically alter persistence.
7. Test the second hit. Use exposed/unexposed and stressed/unstressed groups to distinguish interaction from an ordinary independent effect of the second stressor.
8. Replicate and accept null results. Use blinded measurement, preregistered endpoints, independent laboratories, and complete dosimetry. If realistic exposures fail to produce the predicted changes, narrow or revise the framework.

Population research needs an equally explicit plan. Link tumor subtype, age, diagnostic era, and reliable exposure histories. Specify latency assumptions before examining results. Report stable and declining categories beside rising ones. Test the proposed relationship rather than drawing it by selecting a convenient start year.

A policy response that does not outrun the evidence

RF Safe’s position is that uncertainty about chronic harm justifies better research, transparent standards review, and practical ways to reduce avoidable exposure. That agenda does not require claiming that the cause of every rising tumor has been found.

The 2021 D.C. Circuit decision in Environmental Health Trust v. FCC required a reasoned explanation for aspects of the FCC’s decision to retain its guidelines, including its response to evidence concerning non-cancer effects. It did not decide that compliant RF exposure causes cancer or replace the numerical limits with new ones. Read the court opinion.

The author advocates repeal of Section 704’s relevant siting preemption, enforcement of Public Law 90-602, renewed federal RF research, and a stronger environmental-health role in exposure guidance. The Clean Ether Act is presented here as RF Safe’s policy proposal. These are advocacy positions, not descriptions of reforms already enacted. The RF Safe policy briefing explains that agenda.

At the household level, the practical emphasis is on distance and connection choices: use speakerphone or a wired headset when appropriate, choose wired data where convenient, and locate transmitting devices away from places where people spend long periods. These choices reduce avoidable close exposure; they are not a guarantee of preventing cancer.

For infrastructure, RF Safe favors fiber and appropriately designed light-based communications where they meet the need. The RF Safe LiFi guide explores that direction, including optical safety considerations. The research collection provides a starting point for examining studies across outcomes.

Compliance is a starting point for accountability. It is not the end of scientific inquiry. RF Safe’s demand is to measure the biology with enough precision to find what a heating-focused assessment could miss—and with enough rigor to discover when a proposed mechanism is wrong.

Frequently asked questions